Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Envoy Medical (COCH) Consolidated Net Income (2022 - 2026)

Envoy Medical's Consolidated Net Income history spans 5 years, with the latest figure at -$6.0 million for Q1 2026.

  • On a quarterly basis, Consolidated Net Income fell 6.37% to -$6.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$24.2 million, a 16.68% decrease, with the full-year FY2025 number at -$23.9 million, down 18.87% from a year prior.
  • Consolidated Net Income hit -$6.0 million in Q1 2026 for Envoy Medical, up from -$6.4 million in the prior quarter.
  • Over the last five years, Consolidated Net Income for COCH hit a ceiling of $12.5 million in Q1 2022 and a floor of -$6.7 million in Q4 2023.
  • Historically, Consolidated Net Income has averaged -$2.4 million across 5 years, with a median of -$4.9 million in 2024.
  • The widest YoY moves for Consolidated Net Income: up 26.63% in 2024, down 785.52% in 2024.
  • Tracing COCH's Consolidated Net Income over 5 years: stood at -$1.7 million in 2022, then plummeted by 299.5% to -$6.7 million in 2023, then rose by 26.63% to -$4.9 million in 2024, then fell by 29.43% to -$6.4 million in 2025, then grew by 6.67% to -$6.0 million in 2026.
  • Business Quant data shows Consolidated Net Income for COCH at -$6.0 million in Q1 2026, -$6.4 million in Q4 2025, and -$6.2 million in Q3 2025.